Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Azacitidine
Related studies linked through entity extraction aliases.
Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Azacitidine in Combination With Mitoxantrone, Etoposide Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Study Examining the Combination of Revlimid (Lenalidomide)and Vidaza (Azacitidine) for Relapsed/Refractory CLL and SLL
- Status
- TERMINATED
- Phase
- PHASE2
Azacitidine in Treating Patients With Chronic Myelomonocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine and Entinostat in Treating Patients With Stage I Non-Small Cell Lung Cancer That Has Been Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE4
Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide
- Status
- TERMINATED
- Phase
- PHASE1
Azacitidine and CAPOX in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Extension to Study AZA PH GL 2003 CL 001 Allowing for Continuation of Azacitidine Treatment in Patients With Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE3
Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine
- Status
- COMPLETED
- Phase
- PHASE2
Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE3
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1